Q2 2021
Released Aug 13, 2021, before the open
10-Q filed Aug 13, 2021, 44 days after period end · 0001493152-21-019696
Q2 2021 · 10-Q
Revenue$9.14M$9.14M +152.3% vs Q2 2020−40.1% vs Q1 2021
Net Income-$1.40M-$1.40M N/M vs Q2 2020N/M vs Q1 2021
EPS Diluted-$0.09-$0.09 N/M vs Q2 2020N/M vs Q1 2021
Gross Profit$4,466,000+249.2%
Operating Income-$1,450,000N/M
Operating Cash Flowderived$4,442,000+1.6%
Free Cash Flowderived$4,132,000−4.8%
Margins · derived
Gross margin48.9%+13.5 pt vs Q2 2020
Operating margin-15.9%−17.5 pt vs Q2 2020
Net margin-15.3%−17.2 pt vs Q2 2020
What the release said
The release
Same quarter
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Revenue | $9.14M | $3.62M | $1.65M | $3.19M |
| Net Income | -$1.40M | $70.00K | -$1.24M | -$259.00K |
| EPS Diluted | -$0.09 | $0.01 | -$0.11 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR